Targeting angiogenesis with integrative cancer therapies.
about
Multiple molecular targets of resveratrol: Anti-carcinogenic mechanismsResveratrol: a review of preclinical studies for human cancer preventionNutraceutical use in late-stage cancer.Ginseng compounds: an update on their molecular mechanisms and medical applicationsThe Peter Brojde lung cancer centre: a model of integrative practice.Panax ginseng modulates cytokines in bone marrow toxicity and myelopoiesis: ginsenoside Rg1 partially supports myelopoiesisEthanol extract of Poria cocos reduces the production of inflammatory mediators by suppressing the NF-kappaB signaling pathway in lipopolysaccharide-stimulated RAW 264.7 macrophagesPLGA nanoparticles loaded with etoposide and quercetin dihydrate individually: in vitro cell line study to ensure advantage of combination therapy.Combined Use of Oligopeptides, Fragment Libraries, and Natural Compounds: A Comprehensive Approach To Sample the Druggability of Vascular Endothelial Growth Factor.Efficacy and Safety of a Chinese Herbal Medicine Formula (RCM-104) in the Management of Simple Obesity: A Randomized, Placebo-Controlled Clinical TrialDose Dependent Dual Effect of Baicalin and Herb Huang Qin Extract on Angiogenesis.Biological and therapeutic activities, and anticancer properties of curcuminChinese medicine and biomodulation in cancer patients--Part one.Effects of dietary polyphenols on gene expression in human vascular endothelial cells.Current evaluation of the millennium phytomedicine- ginseng (II): Collected chemical entities, modern pharmacology, and clinical applications emanated from traditional Chinese medicine.A new dawn for the use of traditional Chinese medicine in cancer therapy.Can the therapeutic gain of radiotherapy be increased by concurrent administration of Asian botanicals?Flavan-3-ols consumption and cancer risk: A meta-analysis of epidemiologic studies.Fighting cancer with red wine? Molecular mechanisms of resveratrol.Recent advances in anti-angiogenic therapy of cancerModulation of angiogenesis by dietary phytoconstituents in the prevention and intervention of breast cancer.Plants of Indian origin in drug discovery.Abrus agglutinin is a potent anti-proliferative and anti-angiogenic agent in human breast cancer.Oridonin inhibits BxPC-3 cell growth through cell apoptosis.EGFR mediates LPA-induced proteolytic enzyme expression and ovarian cancer invasion: inhibition by resveratrolInhibition of Hydrogen Sulfide-induced Angiogenesis and Inflammation in Vascular Endothelial Cells: Potential Mechanisms of Gastric Cancer Prevention by Korean Red Ginseng.Improved delivery of angiogenesis inhibitors from PLGA:poloxamer blend micro- and nanoparticles.(+)-Catechin inhibits tumour angiogenesis and regulates the production of nitric oxide and TNF-alpha in LPS-stimulated macrophages.EGHB010, a Standardized Extract of Paeoniae Radix and Glycyrrhizae Radix, Inhibits VEGF-Induced Tube Formation In Vitro and Retinal Vascular Leakage and Choroidal Neovascularization In Vivo.Aster koraiensis Extract and Chlorogenic Acid Inhibit Retinal Angiogenesis in a Mouse Model of Oxygen-Induced Retinopathy.Clinical Safety of Combined Targeted and L. Therapy in Oncological Patients
P2860
Q24648759-BF17C5EF-5911-4B1A-B83F-7C362F9A7235Q24675163-5A826F9D-3D66-4813-94F5-8023246299DEQ27693359-7FCA7B47-24C4-4167-8183-1EB99744D1A2Q28251905-5422C0BE-F51A-4FD4-8E12-5F9C7D38AEDCQ30417605-62C53458-53B6-4218-9902-6C7E223B5693Q34241632-AF5B9E19-568F-42AC-9A24-870B6C9C9180Q35120661-D253F2F6-16BF-4E6B-9516-6E9F5B04D896Q35673296-5639F433-5D27-476C-ACAC-882AFDE6285AQ35836815-28ACFDFD-5666-4A60-9FF3-96788E2437EFQ35895759-CF29623E-1ED8-4370-ADFF-978C1DC2466CQ36208194-FD1EE67C-F95F-47A1-998E-62134A825C72Q36334519-A203E7D7-5697-43CC-A530-BD288C422261Q36485229-ED377F14-CB4F-40F1-925F-A217CA83B332Q37072010-C0253297-DB1E-43DD-8CF3-CD38DEAEEE33Q37368051-4E4B84B8-C6B7-41DE-978F-F7313A61DCCFQ37418257-ED9B64DD-8509-4F4B-9A7D-FCA8FF8AC5B9Q37665033-B7A0D3E7-7177-40D9-B62F-7B922489C295Q37687437-9365A402-1499-47F3-8796-6A3AE3F5EF1AQ37742528-4C2EA0D9-9FB4-4CC4-A075-F94E27215260Q37852512-698C78B3-24F1-442C-8091-72215A797404Q37962472-24110C1D-C238-44AA-9BDA-058D8032A2E5Q38089143-41DE9A5C-D609-4276-8469-0E4E2E61EF1FQ38791117-5D1C7A08-AE09-450A-A43C-E126677D0242Q38912986-CF547D1C-471F-4828-8056-43727BB0F20DQ39249383-9827A6F0-D883-42F5-95B6-244B2C8854B6Q40878415-740FBBB1-7F10-447A-8732-6AA8BA78E7E1Q45309827-E6151DB7-AE03-4A23-A1BE-2B22F77FB123Q46533341-81B8457F-1CC3-4E3B-8263-73103A8D209EQ47758215-7AB606BC-8BB4-47B4-8821-F1289F217911Q55018025-A388CE65-2EEB-4AE3-A2A8-4B02344C1A70Q58760840-79F5D4C7-4249-4C70-A508-41D3C2E945A3
P2860
Targeting angiogenesis with integrative cancer therapies.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Targeting angiogenesis with integrative cancer therapies.
@ast
Targeting angiogenesis with integrative cancer therapies.
@en
Targeting angiogenesis with integrative cancer therapies.
@nl
type
label
Targeting angiogenesis with integrative cancer therapies.
@ast
Targeting angiogenesis with integrative cancer therapies.
@en
Targeting angiogenesis with integrative cancer therapies.
@nl
prefLabel
Targeting angiogenesis with integrative cancer therapies.
@ast
Targeting angiogenesis with integrative cancer therapies.
@en
Targeting angiogenesis with integrative cancer therapies.
@nl
P2860
P356
P1476
Targeting angiogenesis with integrative cancer therapies.
@en
P2093
Donald R Yance
Stephen M Sagar
P2860
P356
10.1177/1534735405285562
P577
2006-03-01T00:00:00Z